Skip to main content
. 2024 Nov 15;78:102928. doi: 10.1016/j.eclinm.2024.102928

Supplementary Figure S2.

Supplementary Figure S2

Kaplan Meier curves for all scoring methods dichotomized at 10% value, using IDFS as clinical endpoint, in the SCAN-B validation cohort. The red curve regards the Low-TILs subgroup (<10%), while the blue curve regards the High-TILs subgroup (≥10%).